The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Evidence that Inositol Polyphosphate 4-Phosphatase Type II Is a Tumor Suppressor that Inhibits PI3K Signaling
Open accessAbstract
We report that knocking down the expression of inositol polyphosphate 4-phosphatase type II (INPP4B) in human epithelial cells, like knockdown of PTEN, resulted in enhanced Akt activation, anchorage-independent growth, and enhanced over all motility. In xenograft experiments overexpression of INPP4B resulted in reduced tumor growth. INPP4B preferentially hydrolyzes phosphatidylinositol-3,4-bisphosphate (PI(3,4)P2) with no effect on phosphatidylinositol-3.4.5-triphosphate (PI(3,4,5)P3), suggesting that PI(3,4)P2 and PI(3,4,5)P3 may cooperate in Akt activation and cell transformation. Dual knockdown of INPP4B and PTEN resulted in cellular senescence. Finally, we find loss-of-heterozygosity (LOH) at the INPP4B locus in a majority of basal-like breast cancers as well as in a significant fraction of ovarian cancers, which correlated with lower over all patient survival, suggesting that INPP4B is a tumor suppressor.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sørlie, T., Perou, C. M., Tibshirani, R., Aas, T., Geisler, S., Johnsen, H., Hastie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191367098 · Cited by 10,938
A biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477
AKT/PKB signaling: navigating downstream
Manning, B. D., & Cantley, L. C. (2007) · Cell · doi:10.1016/j.cell.2007.06.009 · Cited by 6,115
Self-citationThe phosphatidylinositol 3-Kinase–AKT pathway in human cancer
Vivanco, I., & Sawyers, C. L. (2002) · Nature Reviews Cancer · doi:10.1038/nrc839 · Cited by 6,056
The phosphoinositide 3-kinase pathway
Cantley, L. C. (2002) · Science · doi:10.1126/science.296.5573.1655 · Cited by 5,621
Self-citationThe evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism
Engelman, J. A., Luo, J., & Cantley, L. C. (2006) · Nature Reviews Genetics · doi:10.1038/nrg1879 · Cited by 3,330
Self-citationThe epithelial–mesenchymal transition: new insights in signaling, development, and disease
Lee, J. M., Dedhar, S., Kalluri, R., & Thompson, E. W. (2006) · The Journal of Cell Biology · doi:10.1083/jcb.200601018 · Cited by 2,019
Debnath, J., Muthuswamy, S. K., & Brugge, J. S. (2003) · Methods · doi:10.1016/s1046-2023(03)00032-x · Cited by 1,995
Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis
Chen, Z., Trotman, L. C., Shaffer, D., Lin, H.-K., Dotan, Z. A., Niki, M., Koutcher, J. A., Scher, H. I., Ludwig, T., Gerald, W., et al. (2005) · Nature · doi:10.1038/nature03918 · Cited by 1,993
Pten is essential for embryonic development and tumour suppression
Cristofano, A. D., Pesce, B., Cordon-Cardo, C., & Pandolfi, P. P. (1998) · Nature Genetics · doi:10.1038/1235 · Cited by 1,516
Self-citationSenescence in premalignant tumours
Collado, M., Gil, J., Efeyan, A., Guerra, C., Schuhmacher, A. J., Barradas, M., Benguría, A., Zaballos, A., Flores, J. M., Barbacid, M., et al. (2005) · Nature · doi:10.1038/436642a · Cited by 1,482 · cited 2×
“Since mutations in K-ras, B-raf, PTEN, and NF-1 have been shown to trigger cellular senescence in vivo (Chen et al., 2005; Collado et al., 2005; Braig et al., 2005; Courtois-Cox et al., 2006; Dankort et al., 2007), we investigated the effect of knocking down PTEN or INPP4B on senescence of HMEC cells.”
BackgroundDirect Regulation of the Akt Proto-Oncogene Product by Phosphatidylinositol-3,4-bisphosphate
Franke, T. F., Kaplan, D. R., Cantley, L. C., & Toker, A. (1997) · Science · doi:10.1126/science.275.5300.665 · Cited by 1,460
Self-citationOncogene-induced senescence as an initial barrier in lymphoma development
Braig, M., Lee, S., Loddenkemper, C., Rudolph, C., Peters, A. H. F. M., Schlegelberger, B., Stein, H., Dörken, B., Jenuwein, T., & Schmitt, C. A. (2005) · Nature · doi:10.1038/nature03841 · Cited by 1,220
Modelling the molecular circuitry of cancer
Hahn, W. C., & Weinberg, R. A. (2002) · Nature Reviews Cancer · doi:10.1038/nrc795 · Cited by 944
Ory, D. S., Neugeboren, B. A., & Mulligan, R. C. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.21.11400 · Cited by 912
Auger, K. R., Serunian, L. A., Soltoff, S. P., Libby, P., & Cantley, L. C. (1989) · Cell · doi:10.1016/0092-8674(89)90182-7 · Cited by 908
Self-citationX chromosomal abnormalities in basal-like human breast cancer
Richardson, A. L., Wang, Z. C., De Nicolo, A., Lu, X., Brown, M., Miron, A., Liao, X., Iglehart, J. D., Livingston, D. M., & Ganesan, S. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.01.013 · Cited by 869
Self-citationNogueira, V., Park, Y., Chen, C.-C., Xu, P.-Z., Chen, M.-L., Tonic, I., Unterman, T., & Hay, N. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.11.003 · Cited by 780
The deubiquitinylation and localization of PTEN are regulated by a HAUSP-PML network
Song, M. S., Salmena, L., Carracedo, A., Egia, A., Lo-Coco, F., Teruya-Feldstein, J., & Pandolfi, P. P. (2008) · Nature · doi:10.1038/nature07290 · Cited by 548
Self-citationBergamaschi, A., Kim, Y. H., Wang, P., Sørlie, T., Hernandez‐Boussard, T., Lonning, P. E., Tibshirani, R., Børresen‐Dale, A., & Pollack, J. R. (2006) · Genes, Chromosomes and Cancer · doi:10.1002/gcc.20366 · Cited by 506
A negative feedback signaling network underlies oncogene-induced senescence
Courtois-Cox, S., Genther Williams, S. M., Reczek, E. E., Johnson, B. W., McGillicuddy, L. T., Johannessen, C. M., Hollstein, P. E., MacCollin, M., & Cichowski, K. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.10.003 · Cited by 501
A Genetic Screen for Candidate Tumor Suppressors Identifies REST
Westbrook, T. F., Martin, E. S., Schlabach, M. R., Leng, Y., Liang, A. C., Feng, B., Zhao, J. J., Roberts, T. M., Mandel, G., Hannon, G. J., et al. (2005) · Cell · doi:10.1016/j.cell.2005.03.033 · Cited by 489
Klippel, A., Kavanaugh, W. M., Pot, D., & Williams, L. T. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.1.338 · Cited by 483
Dankort, D., Filenova, E., Collado, M., Serrano, M., Jones, K., & McMahon, M. (2007) · Genes & Development · doi:10.1101/gad.1516407 · Cited by 481
Frech, M., Andjelkovic, M., Ingley, E., Reddy, K. K., Falck, J. R., & Hemmings, B. A. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.13.8474 · Cited by 446
Akt-dependent transformation: there is more to growth than just surviving
Plas, D. R., & Thompson, C. B. (2005) · Oncogene · doi:10.1038/sj.onc.1209097 · Cited by 429
Saal, L. H., Gruvberger-Saal, S. K., Persson, C., Lövgren, K., Jumppanen, M., Staaf, J., Jönsson, G., Pires, M. M., Maurer, M., Holm, K., et al. (2008) · Nature Genetics · doi:10.1038/ng.2007.39 · Cited by 355
Etemadmoghadam, D., deFazio, A., Beroukhim, R., Mermel, C., George, J., Getz, G., Tothill, R., Okamoto, A., Raeder, M. B., AOCS Study Group, et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1564 · Cited by 302
Self-citationWhitman, M., Kaplan, D., Roberts, T., & Cantley, L. (1987) · Biochemical Journal · doi:10.1042/bj2470165 · Cited by 300
Self-citationModeling Genomic Diversity and Tumor Dependency in Malignant Melanoma
Lin, W. M., Baker, A. C., Beroukhim, R., Winckler, W., Feng, W., Marmion, J. M., Laine, E., Greulich, H., Tseng, H., Gates, C., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2615 · Cited by 297
Self-citationHuman mammary epithelial cell transformation through the activation of phosphatidylinositol 3-kinase
Zhao, J. J., Gjoerup, O. V., Subramanian, R. R., Cheng, Y., Chen, W., Roberts, T. M., & Hahn, W. C. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00088-6 · Cited by 279
Absence of the lipid phosphatase SHIP2 confers resistance to dietary obesity
Sleeman, M. W., Wortley, K. E., Lai, K.-M. V., Gowen, L. C., Kintner, J., Kline, W. O., Garcia, K., Stitt, T. N., Yancopoulos, G. D., Wiegand, S. J., et al. (2005) · Nature Medicine · doi:10.1038/nm1178 · Cited by 254
The PTEN tumor suppressor protein: an antagonist of phosphoinositide 3-kinase signaling
Vazquez, F., & Sellers, W. R. (2000) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(99)00032-3 · Cited by 224
Naylor, T. L., Greshock, J., Wang, Y., Colligon, T., Yu, Q., Clemmer, V., Zaks, T. Z., & Weber, B. L. (2005) · Breast Cancer Research · doi:10.1186/bcr1356 · Cited by 212
Scheid, M. P., Huber, M., Damen, J. E., Hughes, M., Kang, V., Neilsen, P., Prestwich, G. D., Krystal, G., & Duronio, V. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m106755200 · Cited by 166
Ong, C. J., Ming-Lum, A., Nodwell, M., Ghanipour, A., Yang, L., Williams, D. E., Kim, J., Demirjian, L., Qasimi, P., Ruschmann, J., et al. (2007) · Blood · doi:10.1182/blood-2007-03-079699 · Cited by 158
High resolution melting for mutation scanning of TP53exons 5–8
Krypuy, M., Ahmed, A. A., Etemadmoghadam, D., Hyland, S. J., Chenevix‐Trench, G., DeFazio, A., Fox, S. B., Brenton, J. D., Bowtell, D. D. L., & Dobrovic, A. (2007) · BMC Cancer · doi:10.1186/1471-2407-7-168 · Cited by 142
Self-citationDiscovery and validation of breast cancer subtypes
Kapp, A. V., Jeffrey, S. S., Langerød, A., Børresen‐Dale, A., Han, W., Noh, D., Bukholm, I. R., Nicolau, M. M., Brown, P. O., & Tibshirani, R. J. (2006) · BMC Genomics · doi:10.1186/1471-2164-7-231 · Cited by 129
Chin, S.-F., Wang, Y., Thorne, N., Teschendorff, A. E., Pinder, S. E., Vias, M., Naderi, A., Roberts, I., Barbosa‐Morais, N. L., García, M. J., et al. (2006) · Oncogene · doi:10.1038/sj.onc.1209985 · Cited by 119
Physiological Functions of Pten in Mouse Tissues.
Kishimoto, H., Hamada, K., Saunders, M. E., Backman, S. A., Sasaki, T., Nakano, T., Mak, T. W., & Suzuki, A. (2003) · Cell Structure and Function · doi:10.1247/csf.28.11 · Cited by 114
The cDNA Cloning and Characterization of Inositol Polyphosphate 4-Phosphatase Type II
Norris, F. A., Atkins, R. C., & Majerus, P. W. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.38.23859 · Cited by 102
Norris, F. A., Auethavekiat, V., & Majerus, P. W. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.27.16128 · Cited by 95
Phosphatidylinositol 3′ Kinase Signaling in Mammary Tumorigenesis
Scheid, M. P., & Woodgett, J. R. (2001) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1023/a:1009520616247 · Cited by 36
Mandl, A., Sarkes, D. A., Carricaburu, V., Jung, V., & Rameh, L. E. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00756-07 · Cited by 32
Self-citationGilby, D. C., Goodeve, A. C., Winship, P. R., Valk, P. J. M., Delwel, R., & Reilly, J. T. (2007) · Leukemia · doi:10.1038/sj.leu.2404864 · Cited by 31
Phosphatidylinositol 4-phosphatase type II is an erythropoietin-responsive gene
Barnache, S., Scolan, E. L., Kosmider, O., Denis, N., & Moreau-Gachelin, F. (2005) · Oncogene · doi:10.1038/sj.onc.1209187 · Cited by 29
Mutational and LOH Analyses of the Chromosome 4q Region in Esophageal Adenocarcinoma
Sterian, A., Kan, T., Berki, A. T., Mori, Y., Olaru, A., Schulmann, K., Sato, F., Wang, S., Paun, B. C., Cai, K., et al. (2006) · Oncology · doi:10.1159/000094444 · Cited by 29
Johannsdottir, H., Jóhannesdóttir, G., Agnarsson, B. A., Eerola, H., Arason, A., Johannsson, O. T., Heikkilä, P., Egilsson, V., Olsson, H. L., Borg, Å., et al. (2004) · PubMed · Cited by 17
Cited by
Nishimura, R., Osako, T., Nishiyama, Y., Tashima, R., Nakano, M., Fujisue, M., Toyozumi, Y., & Arima, N. (2013) · Oncology · doi:10.1159/000353099 · Cited by 13,166
Comprehensive molecular portraits of human breast tumours
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11412 · Cited by 12,129
AKT/PKB Signaling: Navigating the Network
Manning, B. D., & Toker, A. (2017) · Cell · doi:10.1016/j.cell.2017.04.001 · Cited by 3,772
Integrative Genomic Profiling of Human Prostate Cancer
Taylor, B. S., Schultz, N., Hieronymus, H., Gopalan, A., Xiao, Y., Carver, B. S., Arora, V. K., Kaushik, P., Cerami, E., Reva, B., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.05.026 · Cited by 3,701
The emerging mechanisms of isoform-specific PI3K signalling
Vanhaesebroeck, B., Guillermet-Guibert, J., Graupera, M., & Bilanges, B. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2882 · Cited by 1,767
Metadata
- Authors
- Gewinner, C., Wang, Z. C., Richardson, A., Teruya-Feldstein, J., Etemadmoghadam, D., Bowtell, D., Barretina, J., Lin, W. M., Rameh, L., Salmena, L., Pandolfi, P. P., & Cantley, L. C.
- Venue
- Cancer Cell
- Publisher
- Elsevier BV
- Published
- 2009-08
- Volume
- 16
- Issue
- 2
- Pages
- 115-125
- ISSN
- 1535-6108 (ISSN-L)
- OpenAlex
- W2012116166
- Cited by
- 461
- References
- 48
- FWCI
- 9.96
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.